Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Marine mammal science 9 (1993), S. 0 
    ISSN: 1748-7692
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Biology
    Notes: Abstract: The bile acid composition of bile obtained from the hepatopancreatic ducts of three species of sperm whales (Cetacea: Physeteridae) was investigated. Bile acids were isolated by adsorption chromatography and analyzed by sequential HPLC, SIMS, and GLC-MS. In each species the dominant bile acids were deoxycholic acid (a secondary bile acid formed by bacterial 7α-dehydroxylation of cholic acid), and chenodeoxycholic acid (a primary bile acid) which together composed more than 86% of biliary bile acids in all three species. In Physeter catodon (sperm whale) deoxycholic acid constituted 79%, and in Kogia breviceps (pygmy sperm whale) it was 61% of biliary bile acids. The sperm whale, which differs from other whales in having a remnant of a large intestine, is the second mammal identified to date in which deoxycholic acid is the predominant bile acid. The high proportion of deoxycholic acid indicates that in the Physeteridae, anaerobic fermentation occurs in its cecum, and that bile acids undergo enterohepatic cycling. Also found were minor proportions of cholic acid, as well as bacterial derivatives of chenodeoxycholic acid (ursodeoxycholic acid, lithocholic acid, and the 12β-epimer of allo-deoxycholic acid). Bile acids were conjugated with taurine in all species; however, in the sperm whale (Physeter) glycine conjugates were present in trace proportions. The bile acid hydroxylation pattern (12α- but not 6α-hydroxylation), lack of primary 5α- (allo) bile acids, and presence of glycine conjugated bile acids suggests the possibility that sperm whales originated from ancient artiodactyls.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    The @journal of physical chemistry 〈Washington, DC〉 99 (1995), S. 16395-16406 
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology , Physics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    World journal of surgery 2 (1978), S. 433-437 
    ISSN: 1432-2323
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    [s.l.] : Nature Publishing Group
    Nature 190 (1961), S. 1106-1107 
    ISSN: 1476-4687
    Source: Nature Archives 1869 - 2009
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Notes: [Auszug] For lipids with melting point above 37, an excess of radioactive material was incubated in bile salt solution with shaking, and the amount of solubilized lipid determined after filtration. For lipids, such as a-mono-olein, which form liquid crystalline suspensions with bile salts when present in ...
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1573-2568
    Keywords: GALLSTONES ; METHYL TERT-BUTYL ETHER ; CONTACT DISSOLUTION ; CHOLELITHIASIS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Topical dissolution of cholesterol gallbladderstones using methyl tert-butyl ether (MTBE) is useful insymptomatic patients judged too ill for surgery.Previous studies showed that ethyl propionate (EP), a C5 ester, dissolves cholesterolgallstones rapidly in vitro, but differs from MTBE inbeing eliminated so rapidly by the liver that bloodlevels remain undetectable. Our aim was to test EP as atopical dissolution agent for cholesterol gallbladderstones. Five high-risk patients underwent topicaldissolution of gallbladder stones by EP. In threepatients, the solvent was instilled via acholecystostomy tube placed previously to treat acutecholecystitis; in two patients, a percutaneoustranshepatic catheter was placed in the gallbladderelectively. Gallstone dissolution was assessed bychromatography, by gravimetry, and by cathetercholecystography. Total dissolution of gallstones wasobtained in four patients after 6-10 hr of lavage; inthe fifth patient, partial gallstone dissolutionfacilitated basketing of the stones. In two patients, cholesteroldissolution was measured and averaged 30 mg/min. Sideeffects were limited to one episode of transienthypotension and pain at the infusion site; no patientdeveloped somnolence or nausea. Gallstone elimination wasassociated with relief of symptoms. EP is an acceptablealternative to MTBE for topical dissolution ofcholesterol gallbladder stones in high-risk patients. The lower volatility and rapid hepaticextraction of EP suggest that it may be preferable toMTBE in this investigational procedure.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1573-2568
    Keywords: URSODEOXYCHOLIC ACID ; CHOLYLSARCOSINE ; PRIMARY BILIARY CIRRHOSIS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We postulated that coadministration ofcholylsarcosine with ursodeoxycholic acid might provideadditional benefit to primary biliary cirrhosis patientswith an incomplete response to ursodeoxycholic acid. Our aim was to test the tolerability and theeffect of adjuvant cholylsarcosine on liver tests andplasma cholesterol in primary biliary cirrhosis patientsreceiving ursodeoxycholic acid. Four primary biliary cirrhosis patients, who, despite more than ayear of ursodeoxycholic acid therapy, had one or moreliver tests persistently equal to or greater than twicethe upper limit of normal, received cholylsarcosine (12-15 mg/kg/day) in addition toursodeoxycholic acid (13-15 mg/kg/day) for six weeks inan open label study. Values of liver tests and plasmacholesterol, determined every two weeks, remainedunchanged. One patient discontinued cholylsarcosine atweek 4 because of new-onset pruritus. Analysis ofduodenal bile acids in one patient showed 52% enrichmentin cholylsarcosine and hydrophilic bile acidsconstituted 87% of total bile acids. It is concluded thatthe addition of cholylsarcosine to ursodeoxycholic aciddid not influence liver tests in four primary biliarycirrhosis patients who had not responded completely to ursodeoxycholic acid alone. Cholylsarcosinewas absorbed and became a dominant biliary bile acid;its administration was associated with increasedpruritus.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1573-2568
    Keywords: small intestinal transit ; imaging and breath tests
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Experiments were carried out in healthy volunteers to explore the utility of a new [14C]lactulose breath test for measuring small intestinal transit time in man and to use this procedure to test whether two antidiarrheal agents, codeine and clonidine, alter small intestinal transit time during digestion of a liquid meal. In an initial validation study performed in 12 subjects (three studies in each subject), a liquid test meal containing 10 g [14C]lactulose was administered and the colonic entry time estimated from the time course of14CO2 excretion in breath compared with that of H2 excretion. There was a fair correlation (r=0.77;P〈0.001) between results obtained by the two methods; both methods gave similar results, but14CO2 output was delayed when compared to H2 output and was incomplete. The meal also contained xylose and [13C]glycine, permitting the duodenal entry time of the meal to be estimated by the appearance of xylose in blood and13CO2 in breath, respectively. The same liquid meal was then used to examine the effect on small intestinal transit time (colonic entry time minus duodenal entry time) of codeine or clonidine.99Tc-sulphur colloid was also added to the meal to permit a comparison of small intestinal transit estimated by imaging with that estimated by the14CO2-lactulose breath test.99Tc radioactivity appeared in the cecum (as assessed using gamma scintigraphy) about 2 hr before14CO2 radioactivity appeared in breath; the correlation between transit time estimated by the two methods was moderate (r=0.61;P〈0.05). Based on the [14C]lactulose data, small intestinal transit time ranged from〈1 to 3 hr for a liquid meal containing 10 g lactulose; within-subject variation (coefficient of variation 17%) was considerably less than between-subject variation (coefficient of variation 56%). Codeine increased the small intestinal transit time significantly (from 2.7±0.3 hr to 5.0 ±0.9 hr; mean±SE), whereas clonidine did not alter small intestinal transit time, as estimated by the colonic entry time minus duodenal entry time. Neither drug influenced duodenal entry time. These results suggest that the [14C]lactulose breath test, which has only moderate accuracy, may have occasional utility as a convenient, noninvasive method for estimating small intestinal transit time in man. However, this study also suggests that indirect methods of estimating small bowel transit in man have limitations, variability, and possibly may lack the desired sensitivity.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1573-2568
    Keywords: steatorrhea ; intestinal resection ; bile salts ; lipid digestion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The efficacy of cholylsarcosine, a synthetic deconjugation-resistant and nonsecretory conjugated bile acid analog for the treatment of fat malabsorption caused by severe bile acid malabsorption, was assessed in an animal model. In two dogs, the ileum and ileocecal valve were resected, causing severe diarrhea, steatorrhea, bile acid malabsorption, and progressive weight loss. Cholylsarcosine was administered as the water-soluble sodium salt by mixing with the dog food. Various doses were explored as well as varying intakes of dog food. Fat absorption was assessed by gravimetric measurement of fecal fat; a nonabsorbable recovery marker (polyethylene glycol mol wt 4000) was used to correct for incomplete fecal collections. Cholylsarcosine caused a 5- to 30-fold increase in fat absorption but had no significant effect on weight loss or fecal weight. Duodenal content was collected during digestion of a meal via a surgically placed Thomas cannula; the aspirates were dilute, acidic, and had a low bile acid concentration. The bile acid concentration increased modestly when cholylsarcosine was administered, but remained below the critical micellization concentration. The results indicate that oral administration of cholylsarcosine improved dietary fat absorption in a canine model of severe bile acid malabsorption with associated steatorrhea and bile acid deficiency in the proximal small intestine. Studies with this compound in patients with nutritional problems because of steatorrhea and severe bile acid malabsorption appear warranted.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1573-2568
    Keywords: ileal pouch-anal anastomosis ; pouchitis ; ulcerative colitis ; familial adenomatous polyposis ; shortchain fatty acids ; bile acids
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Construction of an ileal reservoir changes the fecal bacterial flora and the fecal composition of bile acids and short-chain fatty acids. We examined the relationships between pouch inflammation (pouchitis) and pouch content, as assessed by analysis of fecal bacteria, bile acids, and short chain fatty acids. Four groups were studied: ileal pouch-anal anastomosis (IPAA) for ulcerative colitis with pouchitis (N=10), IPAA without pouchitis (N=5), IPAA for familial adenomatous polyposis without pouchitis (N=5); and Brooke ileostomy for ulcerative colitis, which served as controls (N=5). Pouchitis was defined as ≥7 points on an 18-point pouchitis disease activity index. Aerobic and anaerobic bacteria were quantitatively cultured. Total aqueous-phase bile acids were measured by thin-layer chromatography and an enzymatic 3α-OH hydroxysteroid dehydrogenase method. Fecal short chain fatty acids were measured by gas liquid chromatography. All patients with an IPAA had higher ratios of anaerobes/aerobes and concentrations of anaerobic gram-negative rods than did patients with an ileostomy. There were no other differences between patient groups with respect to bacteria, aqueous-phase total bile acids, or fecal short-chain fatty acids. Fecal concentrations of bacteria, bile acids, and short-chain fatty acids were similar in patients with and without pouchitis, indicating that these factors can not be the sole cause of pouchitis.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1573-2568
    Keywords: CHRONIC PANCREATITIS ; EXOCRINE PANCREATIC INSUFFICIENCY ; ENZYME REPLACEMENT THERAPY ; PANCREATIN ; ENTERIC-COATED MICROSPHERE THERAPY ; ERBIUMOXIDE ; GASTRIC EMPTYING
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract It has been suggested that enteric-coatedpancreatin microsphere (ECPM) preparations with spheresizes larger than 1.7 mm pass through the stomach at aslower rate than a meal and therefore may be less efficacious in restoring pancreatic enzymeactivity than preparations with smaller sphere sizes.The aim of this study was to investigate the gastrictransit profile of a 2-mm ECPM preparation in relation to that of a solid meal and to simultaneouslymeasure enzyme activities in eight patients withpancreatic exocrine insufficiency due to chronicpancreatitis. Gastric transit was assessed bydouble-isotope scintigraphy. A pancake was labeled with99mTc. A 2-mm ECPM preparation was labeledwith 171Er. Intraluminal pancreatic enzymeactivities were assessed during a 6-hr period with thecholesteryl-[14C]octanoate breath test (for carboxyl ester lipaseactivity) and the N -benzoyl-L-tyrosyl-p aminobenzoicacid/p-aminosalicylic acid (NBT-PABA/PAS) test (forchymotrypsin activity). The ECPM preparation passedthrough the stomach more rapidly (median 24 min) thanthe pancake (median 52 min, P 〈 0.05). During ECPMtherapy, mean cumulative 14CO2outputs rose significantly from 30% to 70% (P 〈0.05), but remained below outcomes in healthy volunteers. Mean cumulative plasmaPABA concentrations rose significantly from 46% to 87%(P 〈 0.05) and were not significantly different fromoutcomes in healthy volunteers. In chronic pancreatitis, a 2-mm ECPM preparation does not pass throughthe stomach more slowly than a solid meal, but in factfaster. Digestion of ester lipids and proteins showed animprovement to subnormal and normal levels,respectively.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...